Continuous Glucose Monitoring in the Management of Gestational Diabetes in Switzerland (DipGluMo): An Open-Label, Single-Centre, Randomized, Controlled Trial.
(Abstracted from Lancet Diabetes Endocrinol 2025;13:591-599) The incidence rate for gestational diabetes mellitus (GDM) is as high as 14%, making it one of the more common complications of pregnancy. Glycemic control is an important factor in the treatment of GDM and includes self-monitoring of blood glucose (SMBG).
